Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Airline Industry Today.
Press releases published on May 1, 2025

DMC Global Reports First Quarter Financial Results
First quarter sales were $159.3 million, up 5% sequentially and down 5% versus Q1 2024 Net income attributable to DMC was $0.7 million Adjusted net income attributable to DMC* was $2.2 million, or $0.11 per diluted share Adjusted EBITDA attributable to DMC …

Option Care Health to Participate in Upcoming Investor Conferences
BANNOCKBURN, Ill., May 01, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, will participate in the following upcoming investor …

Wag! To Report First Quarter 2025 Financial Results on May 12, 2025
SAN FRANCISCO, May 01, 2025 (GLOBE NEWSWIRE) -- Wag! Group Co., (the “Company” or “Wag!”, Nasdaq: PET), which strives to be the number one platform to solve the service, product, and wellness needs of the modern U.S. pet household, today announced that it …

Pulmonx to Present at the Bank of America Securities 2025 Health Care Conference
REDWOOD CITY, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the company will be presenting at the Bank of America Securities …

Barfresh Announces First Quarter 2025 Results
Revenue Increased 4% Year-Over-Year to $2.9 Million for First Quarter 2025, In Line with Previous Guidance Achieved Gross Margin of 31% for First Quarter 2025, Exceeding Guidance Co-Manufacturing Partners on Track to Reach Full Production Capability by End …

iRhythm Technologies Announces First Quarter 2025 Financial Results
SAN FRANCISCO, May 01, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three …

NextCure Provides Business Update and Reports First Quarter 2025 Financial Results
Dosing cohort 3 of the Phase 1 trial of LNCB74 (B7-H4 ADC) in multiple cancers and plan to initiate backfill cohorts in the second half of 2025 Plan to provide a proof of concept data readout in the first half of 2026 Cash of approximately $55.9 million …

Genelux Corporation to Participate in a Fireside Chat at the Citizens Life Sciences Conference
WESTLAKE VILLAGE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, CEO and Chairman of the Board, and Matt Pulisic, CFO, will …

Streamline Health® Announces New eValuator™ Contract with Ohio-Based Health System
ATLANTA, May 01, 2025 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of solutions that enable healthcare providers to improve financial performance, announced that it has signed a new contract for the use of …

Zoom to Release Financial Results for the First Quarter of Fiscal Year 2026
SAN JOSE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Zoom Communications, Inc. (NASDAQ: ZM) today announced it will release its financial results for the first quarter of fiscal year 2026 on Wednesday, May 21, 2025, after the market closes. A live Zoom …

3 Million Itron Intelis Gas Meters and Counting: Peoples Natural Gas Receives Milestone Meter
LIBERTY LAKE, Wash., May 01, 2025 (GLOBE NEWSWIRE) -- Itron, Inc. (NASDAQ: ITRI), which is innovating new ways for utilities and cities to manage energy and water, marks a significant milestone with the 3 millionth shipment of its Itron’s Intelis® gas …

SPX Reports First Quarter 2025 Results
CHARLOTTE, N.C., May 01, 2025 (GLOBE NEWSWIRE) -- SPX Technologies, Inc. (NYSE:SPXC) (“SPX”, the “Company”, “we” or “our”) today reported results for the first quarter ended March 29, 2025. First Quarter Highlights (amounts presented for continuing …

Draganfly Announces Proposed Public Offering of Common Shares & Warrants
Saskatoon, SK., May 01, 2025 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”), a drone solutions, and systems developer, today announced it has commenced an underwritten public offering in the United …

Adaptive Biotechnologies Reports First Quarter 2025 Financial Results
SEATTLE, May 01, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to …

Zevra Therapeutics to Participate in the Citizens Life Science Conference
CELEBRATION, Fla., May 01, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage rare disease therapeutics company, today announced that members of Zevra’s executive leadership team will participate …

TEN Ltd. Announces Delivery and Naming of First Two in Series of Twelve DP2 Shuttle Tanker Orders at Samsung Heavy Industries, South Korea
$3.7 billion of minimum contracted revenues from 82 vessel pro-forma fleet 16-vessel shuttle tanker fleet making TEN on the largest shuttle tanker owners in world ATHENS, Greece, May 01, 2025 (GLOBE NEWSWIRE) -- TEN, Ltd. (TEN) (NYSE: TEN) (the “Company”) …

Kura Oncology Reports First Quarter 2025 Financial Results
– NDA submitted in 1Q 2025 for ziftomenib for the treatment of adult patients with relapsed or refractory AML with an NPM1 mutation – – Data from Phase 1b/2 registration-directed trial of ziftomenib selected for oral presentation at ASCO Annual Meeting – – …

OptimizeRx Releases 2025 Environmental, Social, and Governance (ESG) Report
WALTHAM, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, has …

89bio Reports First Quarter 2025 Financial Results and Corporate Updates
– Topline histology data from ENLIGHTEN-Fibrosis and ENLIGHTEN-Cirrhosis Phase 3 trials are expected in 1H 2027 and in 2028, respectively; each trial is designed to support accelerated approval to treat patients with metabolic dysfunction-associated …

Casella Waste Systems, Inc. Announces First Quarter 2025 Results
RUTLAND, Vt., May 01, 2025 (GLOBE NEWSWIRE) -- Casella Waste Systems, Inc. (NASDAQ: CWST), a regional solid waste, recycling and resource management services company, today reported its financial results for the three-month period ended March 31, 2025. Key …